Received Jun 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
patient did not receive both components of the Shingrix vaccine; patient did not receive both components of the Shingrix vaccine; This non-serious case was reported by a physician via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: patient did not receive both components of the Shingrix vaccine) and inappropriate dose of vaccine administered (Verbatim: patient did not receive both components of the Shingrix vaccine). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date: 06-JUN-2025 Reporter asked about the protocol if patient did not receive both components of the Shingrix vaccine during their first dose in the series, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.